INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 2,000 | +1900.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -80.0% | 100 | -76.7% | 0.00% | – |
| Q2 2017 | $5,000 | +400.0% | 430 | +330.0% | 0.00% | – |
| Q1 2017 | $1,000 | -90.0% | 100 | -87.5% | 0.00% | – |
| Q3 2016 | $10,000 | -16.7% | 800 | -17.4% | 0.00% | – |
| Q2 2016 | $12,000 | -20.0% | 968 | -0.7% | 0.00% | – |
| Q1 2016 | $15,000 | -66.7% | 975 | -38.8% | 0.00% | – |
| Q4 2015 | $45,000 | +73.1% | 1,594 | +68.5% | 0.00% | – |
| Q3 2015 | $26,000 | -95.5% | 946 | -94.1% | 0.00% | -100.0% |
| Q2 2015 | $572,000 | +52.5% | 15,930 | +147.3% | 0.00% | – |
| Q1 2015 | $375,000 | +38.4% | 6,441 | 0.0% | 0.00% | – |
| Q4 2014 | $271,000 | +105.3% | 6,441 | +89.4% | 0.00% | – |
| Q3 2014 | $132,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,257,094 | $92,697,000 | 13.04% |
| JW Asset Management, LLC | 388,346 | $11,052,000 | 4.00% |
| Anson Funds Management LP | 400,200 | $11,390,000 | 3.31% |
| Orbimed Advisors | 4,081,800 | $116,168,000 | 1.17% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,718,487 | $48,908,000 | 1.05% |
| Bellevue Asset Management AG | 210,000 | $5,977,000 | 0.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 788,534 | $22,441,000 | 0.93% |
| Rock Springs Capital Management LP | 308,000 | $8,766,000 | 0.71% |
| JUNCTURE WEALTH STRATEGIES, LLC | 18,502 | $527,000 | 0.43% |
| B. Riley Wealth Management, Inc. | 8,600 | $244,000 | 0.35% |